Skip to main content
. 2017 May 24;8(40):66784–66795. doi: 10.18632/oncotarget.18158

Table 6. Univariate Cox regression analysis result for TNM stage in the 7th& 8th editions, both for clinical & pathological TNM stages separately.

7thcTNM N events MST(m) HR P-value
IA 23,531 14,626 29.6 - -
IB 15,712 11,625 18.9 IB vs IA: 1.44 <0.001
IIA 12,239 9,527 15.2 IIA vs IB: 1.16 <0.001
IIB 11,225 8,865 13.4 IIB vs IIA: 1.05 <0.001
IIIA 62,045 49,851 13.5 IIIA vs IIB: 1.02 <0.04
IIIB 29,763 24,911 11.6 IIIB vs IIIA: 1.14 <0.001
IV 67,596 59,133 5.8 IV vs IIIB: 1.62 <0.001
8thcTNM N events MST(m) HR P-value
IA1 1443 799 35.4 - -
IA2 10,616 6,279 33.7 IA2 vs IA1:1.1 0.11
IA3 11,472 7,548 26.1 IA3 vs IA2: 1.2 < 0.001
IB 10,952 8,003 20.2 IB vs IA3: 1.2 < 0.001
IIA 5,503 4,200 16.0 IIA vs IB: 1.2 < 0.001
IIB 17,644 13,713 15.5 IIB vs IIA: 1.0 < 0.001
IIIA 46,822 37,083 14.3 IIIA vs IIB: 1.1 < 0.001
IIIB 41,140 34,121 11.7 IIIB vs IIIA: 1.2 < 0.001
IIIC 8,923 7,659 10.6 IIIC vs IIIB: 1.1 < 0.001
IVA 57,776 50,236 6.3 IVA vs IIIC: 1.4 < 0.001
IVB 9,820 8,897 3.6 IVB vs IVA: 1.5 < 0.001
7th pTNM N events MST(m) HR P-value
IA 339 141 114.8 - -
IB 224 130 61.1 IB vs IA: 1.66 < 0.001
IIA 171 118 46.3 IIA vs IB: 1.37 0.01
IIB # 67 48.0 IIB vs IIA: 0.84 0.25
IIIA # 137 30.1 IIIA vs IIB: 1.67 < 0.001
IIIB # * 42.0 IIIB vs IIIA: 0.66 0.32
IV 797 506 21.8 IV vs IIIB: 1.71 0.19
8th pTNM N events MST(m) HR P-value
IA1 34 * - - -
IA2 165 64 116.0 IA2 vs IA1:1.87 0.12
IA3 140 70 85.3 IA3 vs IA2: 1.42 0.04
IB # 91 69.0 IB vs IA3: 1.18 0.29
IIA # 44 36.2 IIA vs IB: 1.47 0.04
IIB # 155 50.3 IIB vs IIA: 0.92 0.62
IIIA 182 143 29.3 IIIA vs IIB: 1.45 <0.001
IIIB # 25 37.3 IIIB vs IIIA: 1.08 0.71
IIIC - - - - -
IVA 768 480 23.0 IVA vs IIIB: 1.12 0.58
IVB 29 26 4.7 IVB vs IVA: 3.18 <0.001

(* indicating suppressed numbers for cell size<11 or # indicating the total number from suppressed cell size in Table 5, according to the requirment of the NCDB)(MST,median survival time).